An interventional study of 60-Day self-guided Emotion Regulation Journal in Mental Health and Emotional Regulation, sponsored by University of Victoria. Completed at 1 site in Canada. Open to participants aged 19 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-08.
Sponsored by University of Victoria · Not applicable, Interventional, and Other
Participants randomized to the intervention group will receive a physical copy of the 60-day emotion regulation journal during the baseline meeting. Participants will also be introduced the purpose of the journal and its intended usage (i.e., daily journaling). Intervention participants will not be offered guidance or feedback on the journal after these initial instructions, in order to emulate an ad libitum usage. Control group participants will not receive any contact with the researchers outside of the planned questionnaires and to receive their journal at the two-month timepoint.
University of Victoria is the lead sponsor of 32 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Participants in the Intervention group are provided with the 60-day self-guided emotion regulation journals upon enrolment in the study. These participants complete surveys at 2 weeks, 1 month, and 2 months. After the 60-day period, these participants also complete an exit interview and a follow-up survey.
Other: 60-Day self-guided Emotion Regulation Journal
Participants in the Waitlist group complete a 2-week, 1-month and 2-month survey. After the 60-day period, they receive access to the 60-day self-guided emotion regulation journal for their own use.
A 60-day self guided journal with activities designed to be completed daily to improve an individual's emotion regulation abilities and habits
Participant Emotion Regulation
Change in participants' emotion regulation abilities and habits assessed using the Emotion Regulation Questionnaire.
Time frame: 2 weeks, 1-month, 2-months, 60 day exit interview, 90 days follow up
Participant Emotion Regulation
Change in participants' emotion regulation abilities and habits assessed using the using the Difficulties in Emotional Regulation.
Time frame: 2 weeks, 1-month, 2-months, 60 day exit interview, 90 days follow up
Adherence
Participants' adherence to the 60-days of activities in the journal assessed using three items: "Currently, what is the last day of the journal you have completed?"; "Have you skipped or not completed any days prior to the latest day you have completed?"; and "Approximately how many minutes do you spend completing a day, within the journal?"
Time frame: 2 weeks, 1-month, 2-months
Experience using journal
Usability and user experience of intervention group collected during exit interview
Time frame: 60 days
Demographics
Age, preferred gender, socio-economic status, ethnicity, educational attainment, and employment status will be collected.
Time frame: Baseline
Mental Health
Depression and anxiety will be assessed using the Hospital Anxiety and Depression Scale. There is a minimum score of 0 and a maximum score of 21 for each anxiety and depression. Individuals with a score of greater than 8 are considered to have considerable symptoms of anxiety and/or depression.
Time frame: 2 weeks, 1-month, 2-months, and 3-month follow up for intervention group
Subjective Well-Being
Subjective well-being will be assessed using the Warwick-Edinburgh Mental Wellbeing Scale. There is a minimum score of 14 and a maximum score of 70. Scores above 51 are above mean population mental well-being while a score below 51 is below mean population mental well-being.
Time frame: 2 weeks, 1-month, 2-months, and 3-month follow up for intervention group
Self-Compassion
Self-Compassion will be assessed using the full version of the Self-Compassion Scale. Minimum score is 1 and Maximum score is 5. Scores from 1-2.5 indicate low self-compassion, 2.5-3.5 indicates moderate, and 3.5-5 indicates high self-compassion.
Time frame: 2 weeks, 1-month, 2-months, and 3-month follow up for intervention group
Physical Activity and Sedentary Behaviour
Past week hours of sitting, walking, mild, moderate, and vigorous physical activity will be assessed using a modified version of the International Physical Activity Questionnaire. A HIGH score consists of vigorous intensity activity on at least 3 days OR 7 or more days of any combination of walking, moderate intensity or vigorous intensity activities. A MODERATE score consists of 3 or more days of vigorous intensity activity and/or walking of at least 30 minutes per day OR 5 or more days of moderate intensity activity and/or walking of at least 30 minutes per day OR 5 or more days of any combination of walking, moderate intensity or vigorous intensity activities. A LOW score is not achieving the high or moderate physical activity levels.
Time frame: 2 weeks, 1-month, 2-month, and 3-month follow up for intervention group
Screen Time
Past week average weekday and weekend occupational and recreational (i.e., leisure) screen time hours will be assessed using four bespoke items (e.g., In the last seven days, on an average weekday, how many hours did you spend using screens for recreational purposes (e.g., watching TV, playing video games)?)
Time frame: 2 weeks, 1-month, 2-month, and 3-month follow up for intervention group
Sleep
Past week average hours of sleep will be assessed using an adapted item from the Pittsburgh Sleep Quality Assessment: 20 "During the past week, how many hours of actual sleep did you get at night?". The minimum score is 0 representing 7 or more hours of sleep and the maximum score is 3 representing less than 5 hours of sleep. The higher the score, the worse the sleep duration.
Time frame: 2 weeks, 1-month, 2-month, and 3-month follow up for intervention group
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Victoria